Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Lifco Dental International AB in connection with the acquisition of Interdental Tanntekniske Laboratorium AS
Mandate

Vinge advises Lifco Dental International AB in connection with the acquisition of Interdental Tanntekniske Laboratorium AS

October 06, 2009

 

Vinge is advising Lifco Dental International AB in connection with its Norwegian subsidiary, LIC Scandenta AS’s acquisition of Interdental Tanntekniske Laboratorium AS. Lifco Dental is the Nordic region’s leading supplier of dental products and is a subsidiary of Lifco AB, which is wholly owned by Carl Bennet AB. Interdental Tanntekniske Laboratorium AS is an importer of dental mechanics products.

Partner Erik Gabrielsson is advising Lifco Dental International AB in connection with the acquisition.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025